Always good to get updates from Philip Newland-Jones on diabetes care.
New NICE updates on the horizon.
SGLT2i value highlighted for new diagnosis of T2DM + CVD risk.
Challenges the clinical inertia with SGLT2i for patient who are frail, female and from ethnic minority backgrounds #PCPAevents